023910.KS · 대한약품

South Korea · RS rating 54 · As of 2026-10-14

Price25,950.00 KRW
1-day change+1.4%
RS rating (overall / 1M / 3M / 12M)54 / 47 / 49 / 51
StageBasing
Composite / Minervini / CANSLIM score26 / 27 / 20
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q-3.3%
Sales growth Q/Q+7.4%
Distance from 52-week high+17.1%
Market cap (USD)$113.2M
Open South Korea in the interactive screener